Efficacy and Safety of LAS41003 in the Treatment of Inflammatory Tinea Pedis

NCT01096472 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Tinea Pedis

Interventions

DRUG: LAS41003
DRUG: LAS189961
DRUG: LAS189962

Sponsor

Almirall, S.A.